The rise of GLP-1 medications has fundamentally changed the conversation around weight management, metabolic health, and long-term wellness. For decades, many individuals struggling with obesity, excess body weight, or weight-related health concerns were often left with limited options beyond traditional dieting, exercise programs, and, in some cases, bariatric surgery. While healthy nutrition and physical activity remain essential components of any wellness strategy, the emergence of GLP-1 receptor agonist medications has created additional treatment pathways that may help certain individuals manage appetite, reduce food cravings, and support long-term weight-management efforts under medical supervision.
As interest in GLP-1 medications continues to grow, telehealth platforms have become increasingly popular because they simplify access to healthcare providers, treatment evaluations, medication management, and ongoing support. One company receiving significant attention in 2026 is Shed, a telehealth-based wellness platform that offers GLP-1 weight-management programs, longevity-focused wellness services, health coaching, provider oversight, and multiple medication delivery formats. The company also recently began highlighting Foundayo®, which it describes as an FDA-approved GLP-1 pill option within its broader wellness ecosystem.
According to information presented by the company, Shed has served more than 150,000 members and reports more than 800,000 pounds lost across its member base. The company also advertises personalized wellness plans, online provider evaluations, ongoing coaching, and access to both FDA-approved and compounded treatment options depending on individual circumstances and provider recommendations. Like many telehealth platforms operating within the metabolic health space, Shed emphasizes convenience, accessibility, and personalized care while allowing patients to receive support from home.
However, consumers researching GLP-1 programs frequently have important questions. How does Shed work? What medications are available? What is Foundayo®? What is the difference between FDA-approved medications and compounded alternatives? Are the advertised weight-loss results realistic? How does the company's guarantee work? And what should prospective patients understand before beginning treatment?
This comprehensive review examines Shed's weight-management programs, medication options, coaching services, provider model, safety considerations, and frequently discussed benefits and limitations to help consumers make informed healthcare decisions.
What Is Shed?
Shed is a telehealth wellness platform focused primarily on weight management, metabolic health, longevity support, and wellness optimization. According to the company, patients can complete an online health assessment, receive review from licensed healthcare providers, and potentially obtain personalized treatment recommendations when clinically appropriate.
The platform markets a broad range of services that extend beyond medication access alone.
According to company materials, Shed offers:
- GLP-1 weight-management programs
- Foundayo® oral GLP-1 options
- GLP-1 injections
- Wegovy® programs
- GLP-1 liquid drops
- GLP-1 lozenges
- Microdose GLP-1 protocols
- Health coaching
- Longevity programs
- Nutrition education
- Community support
- Ongoing provider follow-up
Unlike traditional weight-loss clinics that require in-person visits, Shed operates primarily through a digital model. Patients can complete assessments online, communicate with providers remotely, receive medications through pharmacy fulfillment services, and access ongoing coaching and educational resources through the company's platform.
This approach reflects a broader trend within healthcare toward virtual care models that prioritize convenience while maintaining provider oversight.
How Shed's GLP-1 Program Works
The company describes a relatively simple four-step process that allows patients to begin treatment without traditional office visits.
The process generally includes:
- Online health assessment
- Provider evaluation
- Prescription approval when appropriate
- Ongoing support and monitoring
Step 1: Complete a Health Assessment
Patients begin by filling out a short online form that gathers information regarding:
- Health history
- Current weight
- Weight-management goals
- Medical conditions
- Medication use
- Preferred administration methods
This information helps providers evaluate whether treatment may be appropriate.
Step 2: Clinical Review
A licensed medical provider reviews the patient's submitted information and determines eligibility.
Potential outcomes may include:
- Treatment approval
- Additional medical questions
- Alternative recommendations
- Requests for further evaluation
Importantly, treatment is not automatically approved. Providers determine eligibility based on individual clinical circumstances.
Step 3: Medication Fulfillment
When treatment is prescribed, medications may be shipped directly to the patient's home through participating pharmacies.
Potential medication options may include:
- FDA-approved medications
- Compounded medications
- Oral options
- Injectable options
Availability varies based on provider recommendations and patient eligibility.
Step 4: Ongoing Support
Unlike programs focused solely on prescriptions, Shed emphasizes continuing support through:
- Health coaching
- Provider communication
- Follow-up appointments
- Wellness education
- Community resources
- Tracking tools
The company positions these services as important components of long-term success.
What Is Foundayo®?
One of the most notable additions highlighted by Shed is Foundayo®, which the company markets as an FDA-approved GLP-1 pill option.
Interest in oral GLP-1 medications has grown rapidly because many consumers prefer alternatives to injections.
Potential reasons patients may explore oral options include:
- Needle avoidance
- Convenience
- Travel flexibility
- Ease of use
- Familiar medication formats
While injectable GLP-1 medications remain among the most widely studied treatment options, oral formulations continue to expand the range of choices available to patients.
Consumers should understand that eligibility, dosing, and treatment recommendations remain individualized and must be determined by licensed healthcare providers.
GLP-1 Medications Available Through Shed
According to company information, multiple treatment pathways may be available through the platform.
These include:
- Foundayo®
- Wegovy®
- GLP-1 injections
- Microdose GLP-1 programs
- Compounded semaglutide
- Compounded tirzepatide
- Lozenges
- Liquid drop formulations
Each option serves different patient preferences and clinical situations.
Wegovy®
Wegovy® is an FDA-approved semaglutide medication indicated for chronic weight management in eligible patients.
Potential areas of support may include:
- Appetite management
- Reduced food cravings
- Calorie reduction
- Long-term weight management
- Behavioral reinforcement
The company references published clinical trial data involving Wegovy® when discussing potential weight-loss outcomes.
Microdose GLP-1 Programs
Shed also promotes microdosing protocols.
According to company materials, microdosing involves lower-dose GLP-1 treatment approaches designed for individualized wellness goals.
Potential areas of interest include:
- Metabolic support
- Wellness optimization
- Appetite awareness
- Personalized dosing strategies
- Long-term sustainability
All dosing decisions remain under provider supervision.
FDA-Approved vs. Compounded GLP-1 Medications
One of the most important distinctions consumers should understand involves FDA-approved medications versus compounded alternatives.
FDA-approved medications include:
- Wegovy®
- Zepbound®
- Ozempic®
- Mounjaro®
These medications have undergone FDA review for approved uses.
Compounded medications differ because they are:
- Prepared by licensed compounding pharmacies
- Customized for specific patient circumstances
- Not FDA-approved as finished products
- Not reviewed by the FDA for safety, effectiveness, or quality in the same manner as approved medications
The company specifically notes that compounded medications are not FDA-approved and require prescription approval following provider evaluation.
Consumers should discuss all risks and benefits with healthcare providers before selecting any treatment pathway.
Shed's Weight-Loss Guarantee
One of the most widely advertised aspects of the platform is its “Lose 10% of your body weight or your money back” guarantee.
This claim understandably attracts consumer attention because guarantees are relatively uncommon within healthcare programs.
The company states that:
- Terms and conditions apply
- Eligibility requirements exist
- Participation requirements may apply
- Full details should be reviewed before enrollment
Consumers should carefully review all guarantee terms before relying on promotional claims.
It is also important to understand that healthcare outcomes can never be guaranteed by medications, providers, or wellness platforms. Individual results vary significantly based on health status, adherence, lifestyle factors, genetics, and other variables.
Beyond Medication: The Shed Wellness Ecosystem
One area where Shed attempts to differentiate itself is through its broader support ecosystem.
According to company information, members may receive access to:
- Health coaches
- Unlimited follow-up appointments
- Nutrition plans
- Educational courses
- Online community resources
- Progress tracking tools
- Mobile applications
- Provider support
Health Coaching
The company emphasizes health coaching as a major component of long-term success.
Potential coaching areas include:
- Habit formation
- Nutrition guidance
- Accountability support
- Behavioral strategies
- Lifestyle optimization
Tracking Technology
Patients may also gain access to tracking tools designed to monitor:
- Weight changes
- Medication schedules
- Progress milestones
- Wellness goals
- Treatment adherence
These systems may help patients remain engaged throughout treatment.
Potential Benefits of Shed
Based on company information, several potential advantages may appeal to consumers.
Possible benefits include:
- Fully online enrollment
- Provider oversight
- Multiple medication options
- Oral and injectable formats
- Ongoing coaching
- Educational resources
- Community support
- Progress tracking
- FSA eligibility
- Home medication delivery
However, no program can guarantee specific outcomes for every participant.
Important Safety Considerations
GLP-1 medications are prescription therapies requiring medical supervision.
Potential considerations may include:
- Nausea
- Vomiting
- Constipation
- Diarrhea
- Abdominal discomfort
- Medication interactions
- Contraindications
- Individual risk factors
Patients should disclose all relevant medical information to healthcare providers before beginning treatment.
Eligibility is determined by providers based on:
- Medical history
- Current medications
- Existing health conditions
- Treatment goals
- Safety considerations
Not every patient will qualify for GLP-1 therapy.
Who May Consider Shed?
The platform may appeal to:
- Adults seeking medically supervised weight management
- Individuals interested in GLP-1 treatment options
- Patients preferring telehealth convenience
- Those interested in coaching support
- Individuals seeking ongoing provider access
- Consumers exploring oral or injectable treatment options
However, treatment decisions should always be made in consultation with qualified healthcare professionals.
Final Verdict
Shed positions itself as a comprehensive telehealth wellness platform focused on weight management, metabolic health, longevity support, and personalized care. By combining provider evaluations, GLP-1 treatment options, coaching services, educational resources, and ongoing support, the company attempts to create a broader wellness ecosystem rather than functioning solely as a prescription provider. The addition of Foundayo® and multiple administration formats may appeal to consumers seeking flexibility and individualized treatment pathways.
At the same time, prospective patients should understand the differences between FDA-approved medications and compounded products, carefully review all program terms and guarantees, and recognize that individual results vary substantially. Healthcare providers—not the platform itself—determine treatment eligibility and prescribing decisions based on each patient's medical circumstances.
Ultimately, Shed may be worth exploring for individuals seeking a telehealth-based weight-management program with provider oversight and ongoing support. As with any healthcare decision, consumers should review all safety information, discuss questions with qualified providers, and make treatment choices based on individualized medical guidance rather than marketing claims alone.
Medical Disclaimer: GLP-1 medications require evaluation and prescription by licensed healthcare providers. Not all patients qualify for treatment. Individual results vary. Compounded medications are not FDA-approved as finished products. This article is for informational purposes only and should not be considered medical advice.